Helen MacDonald

And I think we've seen some increasing national awareness and campaigns building around this this week.

And it relates to the issue, I think, of mapping out what are the highest value activities that we do in health care to look after people, both to address their acute medical problems, perhaps also to reduce unnecessary admissions or consultations when people are very busy with COVID.

And in the longer term, what aspects of more routine care, chronic disease management or screening are most important and valuable to our health care systems?

I was really interested to see a paper, which is perhaps the beginning of this story, which was posted on CBM, Carl.

So you may have seen it.

So I guess we call it the kind of preprint article.

It was authored by Charitini Stavrapoulou at the University of London, working with international colleagues.

And it was looking at common conditions linked to preventable admission to hospital.

and found that influenza, COPD, heart failure, diabetes, urine infections and cellulitis were some of the top reasons for admission, where there seemed to be scope to reduce admissions from those situations from primary care.

But major anti-climax, they're not sure what these are.

So I'd be interested to know, Carl, your thoughts on where do you think this evidence about what we should stop or start doing is going to come from?

You know, I didn't mention health checks because I was betting in my head whether you would have to bring them up, possibly for the third time.

I will.

This came as a request, actually.

Some people were asking about thrombosis and coagulopathy and COVID.

And I think increasingly we're understanding that this virus gets around your body and does all kinds of things which we don't completely understand.

But anecdotally, we've heard people say that they're seeing more PE and more so perhaps in COVID patients, so they don't have any good evidence on those reports.

And there was a new paper out in JAMA a few days ago, which asked what the characteristics, clinical presentation and outcomes of patients hospitalised with coronavirus disease in the US were.

They looked at 5,700 consecutive patients hospitalized with swab confirmed COVID-19 in the New York City area.

And for around 3,000 of those patients who remained hospitalized when the study closed, they were missing outcomes for about half of those people and more so in older people.